aluates Reports

$ 0.0

Automative

Global Breast Cancer Predictive Genetic Testing Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-8H2451

Global Breast Cancer Predictive Genetic Testing Market Insights and Forecast to 2028

BUY CHAPTERS

Global Breast Cancer Predictive Genetic Testing Market Research Report 2025

Code: QYRE-Auto-8H2451

Report

September 2025

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Thermo Fisher Scientific

PerkinElmer Inc

Quest Diagnostics

Myriad Genetics

Iverson Genetics

Cancer Genetics

OncoCyte Corporation

NeoGenomics

Invitae

Breast Cancer Predictive Genetic Testing Market

The global market for Breast Cancer Predictive Genetic Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Breast Cancer Predictive Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Breast Cancer Predictive Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Breast Cancer Predictive Genetic Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Breast Cancer Predictive Genetic Testing include Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation, NeoGenomics, Invitae, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Breast Cancer Predictive Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Predictive Genetic Testing.

The Breast Cancer Predictive Genetic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Breast Cancer Predictive Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Breast Cancer Predictive Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Breast Cancer Predictive Genetic Testing Market Report

Report Metric	Details
Report Name	Breast Cancer Predictive Genetic Testing Market
Segment by Type	High Penetrant Genes Intermediate Penetrant Genes Low Penetrant Genes
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation, NeoGenomics, Invitae
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Predictive Genetic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Breast Cancer Predictive Genetic Testing Market report?

Ans: The main players in the Breast Cancer Predictive Genetic Testing Market are Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation, NeoGenomics, Invitae

What are the Application segmentation covered in the Breast Cancer Predictive Genetic Testing Market report?

Ans: The Applications covered in the Breast Cancer Predictive Genetic Testing Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Breast Cancer Predictive Genetic Testing Market report?

Ans: The Types covered in the Breast Cancer Predictive Genetic Testing Market report are High Penetrant Genes, Intermediate Penetrant Genes, Low Penetrant Genes

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 High Penetrant Genes

1.2.3 Intermediate Penetrant Genes

1.2.4 Low Penetrant Genes

1.3 Market by Application

1.3.1 Global Breast Cancer Predictive Genetic Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Breast Cancer Predictive Genetic Testing Market Perspective (2020-2031)

2.2 Global Breast Cancer Predictive Genetic Testing Growth Trends by Region

2.2.1 Global Breast Cancer Predictive Genetic Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Breast Cancer Predictive Genetic Testing Historic Market Size by Region (2020-2025)

2.2.3 Breast Cancer Predictive Genetic Testing Forecasted Market Size by Region (2026-2031)

2.3 Breast Cancer Predictive Genetic Testing Market Dynamics

2.3.1 Breast Cancer Predictive Genetic Testing Industry Trends

2.3.2 Breast Cancer Predictive Genetic Testing Market Drivers

2.3.3 Breast Cancer Predictive Genetic Testing Market Challenges

2.3.4 Breast Cancer Predictive Genetic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Breast Cancer Predictive Genetic Testing Players by Revenue

3.1.1 Global Top Breast Cancer Predictive Genetic Testing Players by Revenue (2020-2025)

3.1.2 Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Players (2020-2025)

3.2 Global Breast Cancer Predictive Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Breast Cancer Predictive Genetic Testing Revenue

3.4 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio

3.4.1 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Predictive Genetic Testing Revenue in 2024

3.5 Global Key Players of Breast Cancer Predictive Genetic Testing Head office and Area Served

3.6 Global Key Players of Breast Cancer Predictive Genetic Testing, Product and Application

3.7 Global Key Players of Breast Cancer Predictive Genetic Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Breast Cancer Predictive Genetic Testing Breakdown Data by Type

4.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Type (2020-2025)

4.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2026-2031)

5 Breast Cancer Predictive Genetic Testing Breakdown Data by Application

5.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Application (2020-2025)

5.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Breast Cancer Predictive Genetic Testing Market Size (2020-2031)

6.2 North America Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Breast Cancer Predictive Genetic Testing Market Size by Country (2020-2025)

6.4 North America Breast Cancer Predictive Genetic Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Breast Cancer Predictive Genetic Testing Market Size (2020-2031)

7.2 Europe Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2020-2025)

7.4 Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size (2020-2031)

8.2 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Breast Cancer Predictive Genetic Testing Market Size (2020-2031)

9.2 Latin America Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2020-2025)

9.4 Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size (2020-2031)

10.2 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Breast Cancer Predictive Genetic Testing Introduction

11.1.4 Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Introduction

11.2.4 Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 PerkinElmer

11.3.1 PerkinElmer Company Details

11.3.2 PerkinElmer Business Overview

11.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Introduction

11.3.4 PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025)

11.3.5 PerkinElmer Recent Development

11.4 Quest Diagnostics

11.4.1 Quest Diagnostics Company Details

11.4.2 Quest Diagnostics Business Overview

11.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Introduction

11.4.4 Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025)

11.4.5 Quest Diagnostics Recent Development

11.5 Myriad Genetics

11.5.1 Myriad Genetics Company Details

11.5.2 Myriad Genetics Business Overview

11.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Introduction

11.5.4 Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025)

11.5.5 Myriad Genetics Recent Development

11.6 Iverson Genetics

11.6.1 Iverson Genetics Company Details

11.6.2 Iverson Genetics Business Overview

11.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Introduction

11.6.4 Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025)

11.6.5 Iverson Genetics Recent Development

11.7 Cancer Genetics

11.7.1 Cancer Genetics Company Details

11.7.2 Cancer Genetics Business Overview

11.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Introduction

11.7.4 Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025)

11.7.5 Cancer Genetics Recent Development

11.8 OncoCyte Corporation

11.8.1 OncoCyte Corporation Company Details

11.8.2 OncoCyte Corporation Business Overview

11.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Introduction

11.8.4 OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025)

11.8.5 OncoCyte Corporation Recent Development

11.9 NeoGenomics

11.9.1 NeoGenomics Company Details

11.9.2 NeoGenomics Business Overview

11.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Introduction

11.9.4 NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025)

11.9.5 NeoGenomics Recent Development

11.10 Invitae

11.10.1 Invitae Company Details

11.10.2 Invitae Business Overview

11.10.3 Invitae Breast Cancer Predictive Genetic Testing Introduction

11.10.4 Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025)

11.10.5 Invitae Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Thermo Fisher Scientific

PerkinElmer Inc

Quest Diagnostics

Myriad Genetics

Iverson Genetics

Cancer Genetics

OncoCyte Corporation

NeoGenomics

Invitae

List of Tables

Table 1. Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of High Penetrant Genes

Table 3. Key Players of Intermediate Penetrant Genes

Table 4. Key Players of Low Penetrant Genes

Table 5. Global Breast Cancer Predictive Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Breast Cancer Predictive Genetic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Breast Cancer Predictive Genetic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Breast Cancer Predictive Genetic Testing Market Share by Region (2020-2025)

Table 9. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Breast Cancer Predictive Genetic Testing Market Share by Region (2026-2031)

Table 11. Breast Cancer Predictive Genetic Testing Market Trends

Table 12. Breast Cancer Predictive Genetic Testing Market Drivers

Table 13. Breast Cancer Predictive Genetic Testing Market Challenges

Table 14. Breast Cancer Predictive Genetic Testing Market Restraints

Table 15. Global Breast Cancer Predictive Genetic Testing Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Breast Cancer Predictive Genetic Testing Market Share by Players (2020-2025)

Table 17. Global Top Breast Cancer Predictive Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Predictive Genetic Testing as of 2024)

Table 18. Ranking of Global Top Breast Cancer Predictive Genetic Testing Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Breast Cancer Predictive Genetic Testing Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Breast Cancer Predictive Genetic Testing, Headquarters and Area Served

Table 21. Global Key Players of Breast Cancer Predictive Genetic Testing, Product and Application

Table 22. Global Key Players of Breast Cancer Predictive Genetic Testing, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Breast Cancer Predictive Genetic Testing Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Type (2020-2025)

Table 26. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Type (2026-2031)

Table 28. Global Breast Cancer Predictive Genetic Testing Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Application (2020-2025)

Table 30. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Application (2026-2031)

Table 32. North America Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Breast Cancer Predictive Genetic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Breast Cancer Predictive Genetic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 47. Roche Company Details

Table 48. Roche Business Overview

Table 49. Roche Breast Cancer Predictive Genetic Testing Product

Table 50. Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025) & (US$ Million)

Table 51. Roche Recent Development

Table 52. Thermo Fisher Scientific Company Details

Table 53. Thermo Fisher Scientific Business Overview

Table 54. Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Product

Table 55. Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025) & (US$ Million)

Table 56. Thermo Fisher Scientific Recent Development

Table 57. PerkinElmer Company Details

Table 58. PerkinElmer Business Overview

Table 59. PerkinElmer Breast Cancer Predictive Genetic Testing Product

Table 60. PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025) & (US$ Million)

Table 61. PerkinElmer Recent Development

Table 62. Quest Diagnostics Company Details

Table 63. Quest Diagnostics Business Overview

Table 64. Quest Diagnostics Breast Cancer Predictive Genetic Testing Product

Table 65. Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025) & (US$ Million)

Table 66. Quest Diagnostics Recent Development

Table 67. Myriad Genetics Company Details

Table 68. Myriad Genetics Business Overview

Table 69. Myriad Genetics Breast Cancer Predictive Genetic Testing Product

Table 70. Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025) & (US$ Million)

Table 71. Myriad Genetics Recent Development

Table 72. Iverson Genetics Company Details

Table 73. Iverson Genetics Business Overview

Table 74. Iverson Genetics Breast Cancer Predictive Genetic Testing Product

Table 75. Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025) & (US$ Million)

Table 76. Iverson Genetics Recent Development

Table 77. Cancer Genetics Company Details

Table 78. Cancer Genetics Business Overview

Table 79. Cancer Genetics Breast Cancer Predictive Genetic Testing Product

Table 80. Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025) & (US$ Million)

Table 81. Cancer Genetics Recent Development

Table 82. OncoCyte Corporation Company Details

Table 83. OncoCyte Corporation Business Overview

Table 84. OncoCyte Corporation Breast Cancer Predictive Genetic Testing Product

Table 85. OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025) & (US$ Million)

Table 86. OncoCyte Corporation Recent Development

Table 87. NeoGenomics Company Details

Table 88. NeoGenomics Business Overview

Table 89. NeoGenomics Breast Cancer Predictive Genetic Testing Product

Table 90. NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025) & (US$ Million)

Table 91. NeoGenomics Recent Development

Table 92. Invitae Company Details

Table 93. Invitae Business Overview

Table 94. Invitae Breast Cancer Predictive Genetic Testing Product

Table 95. Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2020-2025) & (US$ Million)

Table 96. Invitae Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Breast Cancer Predictive Genetic Testing Picture

Figure 2. Global Breast Cancer Predictive Genetic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Breast Cancer Predictive Genetic Testing Market Share by Type: 2024 VS 2031

Figure 4. High Penetrant Genes Features

Figure 5. Intermediate Penetrant Genes Features

Figure 6. Low Penetrant Genes Features

Figure 7. Global Breast Cancer Predictive Genetic Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Breast Cancer Predictive Genetic Testing Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Breast Cancer Predictive Genetic Testing Report Years Considered

Figure 13. Global Breast Cancer Predictive Genetic Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Breast Cancer Predictive Genetic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Breast Cancer Predictive Genetic Testing Market Share by Region: 2024 VS 2031

Figure 16. Global Breast Cancer Predictive Genetic Testing Market Share by Players in 2024

Figure 17. Global Top Breast Cancer Predictive Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Predictive Genetic Testing as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Breast Cancer Predictive Genetic Testing Revenue in 2024

Figure 19. North America Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Breast Cancer Predictive Genetic Testing Market Share by Country (2020-2031)

Figure 21. United States Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Breast Cancer Predictive Genetic Testing Market Share by Country (2020-2031)

Figure 25. Germany Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Share by Region (2020-2031)

Figure 33. China Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Breast Cancer Predictive Genetic Testing Market Share by Country (2020-2031)

Figure 41. Mexico Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Share by Country (2020-2031)

Figure 45. Turkey Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Roche Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2020-2025)

Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2020-2025)

Figure 50. PerkinElmer Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2020-2025)

Figure 51. Quest Diagnostics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2020-2025)

Figure 52. Myriad Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2020-2025)

Figure 53. Iverson Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2020-2025)

Figure 54. Cancer Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2020-2025)

Figure 55. OncoCyte Corporation Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2020-2025)

Figure 56. NeoGenomics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2020-2025)

Figure 57. Invitae Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cancer Genomic Testing Market Research Report 2024

Global Genomic Testing in Cancer Market Research Report 2024

Global Next Generation Tumor Genetic Testing Market Research Report 2024

Global DNA Genetic Testing Market Research Report 2024

Cancer Gene Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pre Pregnancy Genetic Testing Market Research Report 2024

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

Global Tumor Gene Test Service Market Research Report 2025

Global Inherited Cancer Genome Testing Market Research Report 2024

Global Lung Cancer Genomic Testing Market Research Report 2024

Rare Disease Genetic Testing Market

Global HPV Genetic Testing Market Research Report 2025

Global Predictive Genetic Testing and Genomics Market Research Report 2025

Global Genetic Testing for Safe Medication Market Research Report 2024

Global Genotyping Test Market Research Report 2025

Global Cancer Oncology Testing Market Research Report 2024

Global Gene Detection for Individualized Cancer Therapy Market Research Report 2024

Global Genetic Disease Diagnostic Market Research Report 2025

Global Custom Genetic Screening Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions